Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

AMD willing to pay you up to $30k via its new bug bounty program

AMD expands its private bug bounty program to the general public, allowing anyone who signs up for an Intigriti account to submit bugs and get paid.

Tom’s Hardware

Texas revamps Narcan distribution following delays, unpredictable supply

Texas has tapped more than $45 million in federal funds to get the overdose-reversing drug into the hands of law enforcement, members of the public. But the program has been plagued by supply issues, delays and lack of communication.

The Texas Tribune

French pharmacists strike to highlight drug shortages and demand better pay

In their first major strike in a decade, pharmacists across France stopped work on Thursday to draw attention to drug shortages, forced closures and potential restrictions on online sales. They also want higher pay.

Radio France Internationale

From analysis to the latest developments in health,
read the most diverse news in one place.

Pharma Firm Urged To Share New 'Game-changer' HIV Drug

More than 300 politicians, health experts and celebrities on Thursday called for US pharmaceutical giant Gilead to allow cheap, generic versions of a promising new HIV drug to be produced so it can reach people in developing countries most affected by the deadly disease.

International Business Times

4 Pharma Stocks to Watch for Surprising Gains in June

Amid growing demand for specialty drugs and increasing adoption of emerging technology in pharmaceutical manufacturing, the pharma industry is witnessing steady expansion. Therefore, quality pharmaceutical stocks Zoetis (ZTS), Viatris (VTRS), MEI Pharma (MEIP), and Amphastar Pharmaceuticals (AMPH) could be ideal additions to your watchlist. Keep reading….

StockNews.com

3 Value Biotech Stocks With Breakout Potential in 2024

Given growing healthcare spending, supportive government policies, and technological innovation, the biotechnology industry is poised for solid long-term growth. Thus, investors could consider buying quality biotech stocks Harmony Biosciences (HRMY), Esperion Therapeutics (ESPR), and Entrada Therapeutics (TRDA), which are trading at a discount. Read on….

StockNews.com

‘Facebook probably knows I sell drugs’ – how young people’s digital footprints can threaten their future prospects

Social media and messaging apps such as Facebook, Instagram, Snapchat and Messenger are increasingly used to buy and sell drugs in many countries. New Zealand is no exception.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

AstraZeneca aims to nearly double revenues to $80bn by 2030

UK’s biggest drugmaker says it plans to launch 20 major new medicines before the end of the decade

The Guardian - UK

'New era of growth': AstraZeneca sets out bold plans for $80bn revenues by 2030

The growth will be fuelled by 20 new drugs that are set to launch this decade

Evening Standard

3 Biotech Stocks Poised for May Surges

The use of advanced technologies, growing demand for personalized medicines, and rising investments in R&D are boosting the biotech industry’s prospects. Given this backdrop, investors could consider buying quality biotech stocks: Amgen (AMGN), Jazz Pharmaceuticals (JAZZ), and ANI Pharmaceuticals (ANIP). Read on.

StockNews.com

3 Pharma Stocks Primed for May Investment Opportunities

The pharma industry is poised for tremendous growth driven by surging healthcare needs, the introduction of groundbreaking medications, and relentless technological innovation. Hence, quality pharma stocks Collegium Pharmaceutical (COLL), Green Thumb Industries (GTBIF), and Bristol-Myers Squibb (BMY) emerge as prime investment options this month. Read more….

StockNews.com

Imagine getting life-saving drugs to sick people without relying on big pharma? We may have found a way

An NHS trust’s attempts to bring a crucial drug to market itself is hopeful news for patients, says Dr Catriona Crombie of the medical charity LifeArc

The Guardian - UK

3 Pharma Stocks to Buy for Potential Financial Fortunes

Amid surging medicine demand and ongoing drug shortages, the pharmaceutical industry thrives, driving improved patient outcomes and promising growth opportunities for investors. So, it could be wise to invest in quality pharma stocks ACADIA Pharmaceuticals (ACAD), Neurocrine Biosciences (NBIX), and Supernus Pharmaceuticals (SUPN), which can help you fetch potential financial…

StockNews.com

3 Top-Rated Pharma Stocks to Diversify Your Portfolio

The pharmaceutical industry is expanding owing to the rising incidence of chronic diseases, increasing investments in R&D, and the use of advanced technologies for drug development and manufacturing. Given this backdrop, investors could consider buying quality pharma stocks such as Elanco Animal Health (ELAN), Viatris (VTRS), and Astellas Pharma (ALPMY),…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

AstraZeneca’s Covid vaccine is no more – but its remarkable success must not be forgotten

Although dogged by controversy, the firm’s coronavirus jab saved the lives of millions and helped avert humanitarian crises in nations unable to access costly alternatives

Dynamite News

Punjab Police busts inter-state illegal pharma supply and manufacturing network

Punjab Police busted an inter-state illegal pharmaceutical supply and manufacturing network operating from a pharma factory in Himachal Pradesh. Read further on Dynamite News:

StockNews.com

Buy Alert: 3 Pharma Stocks Under $20 to Invest in Now

With rising medicine demand and drug shortages in the U.S., pharmaceutical stocks under $20 present lucrative opportunities for investors, promising substantial returns in a ripe market. So, I think fundamentally solid pharma stocks ACADIA Pharmaceuticals (ACAD), Amneal Pharmaceuticals (AMRX), and OptiNose (OPTN), which are currently trading under $20, could be…

International Business Times

Weight-loss Drug Maker Novo Nordisk's Profits Soar Further

The drugmaker increased its market share of the diabetic treatment market by 1.8 percentage points and now has a 34-percent share of the market.

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

How much have NHS prescriptions increased to and who doesn't have to pay?

Pharmacists are concerned the recent rise in the cost of NHS drugs will mean more people won’t be able to afford all the medication they need

StockNews.com

3 Top Pharma Stocks for May 2024

The pharmaceutical sector is experiencing rapid growth, driven by the ever-rising healthcare needs and the adoption of advanced technologies. Against this backdrop, fundamentally strong pharmaceutical stocks such as Teva Pharmaceutical Industries (TEVA), Neurocrine Biosciences (NBIX), and GSK plc (GSK) could be solid portfolio additions for May. Read on.

The Guardian - UK

Revealed: UK government was warned of infected blood risks in 1970s

Documents show officials were told blood plasma harvested from US convicts was contaminated with viruses

The Guardian - UK

‘Plasma was called liquid gold’: the true story of the UK infected blood scandal

Documents examined by inquiry show officials knew people were being given infected blood products, but sanctioned their use

Evening Standard

AstraZeneca's £18.7m boss Soriot bounces back as pharma giant reveals 18% sales growth

Soriot came under fire this month for his £18.7 million pay packet

The Guardian - AU

Experts warn of influx of synthetic opioids amid calls for second Melbourne injecting room

Use of deadly nitazines is on the rise in Australia and a suite of measures is needed to prevent more fatalities, former New Zealand prime minister Helen Clark says

The Guardian - UK

People with MND in England and Wales fear losing access to life-extending drug

NHS cost threshold has not been raised by National Institute for Health and Care Excellence since 2004

1 … 29 30 31 32

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations